Bicyclic benzamide compound as histamine H3 receptor ligand useful in the treatment of neurological diseases
US7446103B2 · kind B2 · utility
9Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2003 |
| Grant date | Nov 4, 2008 |
| Priority date | — |
| Expiry date | Jan 23, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel bicyclic benzamide derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.